E25Bio Raises $2M Seed From Khosla Ventures
SeedVenture Capital

E25Bio Raises $2M Seed From Khosla Ventures

•Mar 31, 2020

Participants

ZoomInfo

ZoomInfo

company

Khosla Ventures

Khosla Ventures

investor

Deal Summary

E25Bio secured a $2M funding round led by Khosla Ventures to develop affordable rapid at‑home COVID-19 antigen tests. The funding supports scaling production and regulatory efforts for imminent test deployment.

Comments

Want to join the conversation?

Loading comments...